No Impact of Vitamin D on the CYP3A Biomarker 4β-Hydroxycholesterol in Patients with Abnormal Glucose Regulation

Open Access

Peer-reviewed

Research Article

Buster Mannheimer ,

* E-mail: buster.mannheimer@sodersjukhuset.se

Affiliation Karolinska Institutet, Department of Clinical Science and Education at Södersjukhuset, SE 118 82, Stockholm, Sweden
⨯
Henrik Wagner,

Affiliation Karolinska Institutet, Department of Molecular Medicine and Surgery, D2:04, SE 171 76, Stockholm, Sweden
⨯
Claes-Göran Östenson,

Affiliation Department of Endocrinology, Metabolism and Diabetes at Karolinska Institutet, Karolinska University Hospital, D2:04, SE 171 76, Stockholm, Sweden
⨯
Ulf Diczfalusy

Affiliation Department of Laboratory Medicine, Division of Clinical Chemistry at Karolinska Institutet, Karolinska University Hospital, C1.74, Huddinge, SE-141 86, Stockholm, Sweden
⨯

Reader Comments (0)

Vitamin D
Is the Subject Area "Vitamin D" applicable to this article?

Thanks for your feedback.
Insulin
Is the Subject Area "Insulin" applicable to this article?

Thanks for your feedback.
Vitamins
Is the Subject Area "Vitamins" applicable to this article?

Thanks for your feedback.
Glucose
Is the Subject Area "Glucose" applicable to this article?

Thanks for your feedback.
Drug metabolism
Is the Subject Area "Drug metabolism" applicable to this article?

Thanks for your feedback.
Drug administration
Is the Subject Area "Drug administration" applicable to this article?

Thanks for your feedback.
Enzyme metabolism
Is the Subject Area "Enzyme metabolism" applicable to this article?

Thanks for your feedback.
Gastrointestinal tract
Is the Subject Area "Gastrointestinal tract" applicable to this article?

Thanks for your feedback.